ACE2 and susceptibility to pneumonia measurement: From the downregulation of ACE2 following SARS-CoV binding to ACE2 and resulting in excessive activation of RAS and exacerbated pneumonia progression, we speculate that rhACE2 which can increase ACE2 levels may become one of the most promising approaches for future treatment and improve the prognosis of patients with COVID-19.